Skip to main content
. 2023 Jul 18;11(7):e5123. doi: 10.1097/GOX.0000000000005123

Table 2.

Treatment Procedures and Details (Safety Population)

Parameter Baseline Follow-up Visit 1
Skin marking grid used
 n/N (%) 54/79 (68.4) 31/33 (93.9)
 Mean application time, min 2.8 5.2
Pretreatment comfort regimen used
 n/N (%) 68/79 (86.1) 29/33 (87.9)
Effectiveness, n/N (%) 63/68 (92.6) 29/29 (100.0)
Patients who received other treatments, n/N (%) 10/79 (12.7) 3/33 (9.1)
Mean number of other treatments given 1.5 1.5
Other treatment categories
 Energy-based devices (eg, laser, ultrasound), n/N (%) 3/79 (3.8) 0/33 (0.0)
 Injectables (eg, botulinum toxin, dermal fillers) 8/79 (10.1) 3/33 (9.1)
 Other (eg, skin booster) 1/79 (1.3) 0/33 (0.0)
Mean time spent for patient consultation, min 20.3
Mean time to administer treatment, min 10.0
Mean time to posttreatment, min 12.1